Kings Path Partners LLC Ligand Pharmaceuticals Inc Transaction History
Kings Path Partners LLC
- $238 Billion
- Q3 2024
A detailed history of Kings Path Partners LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Kings Path Partners LLC holds 8,260 shares of LGND stock, worth $984,509. This represents 0.35% of its overall portfolio holdings.
Number of Shares
8,260
Previous 6,880
20.06%
Holding current value
$984,509
Previous $580 Million
42.61%
% of portfolio
0.35%
Previous 0.27%
Shares
2 transactions
Others Institutions Holding LGND
# of Institutions
257Shares Held
18.2MCall Options Held
26.8KPut Options Held
9.3K-
Black Rock Inc. New York, NY2.87MShares$342 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.97MShares$235 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.01MShares$120 Million0.05% of portfolio
-
Macquarie Group LTD Australia, C3887KShares$106 Million0.1% of portfolio
-
State Street Corp Boston, MA707KShares$84.3 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $2.01B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...